References

Allerlux

Proven anti-allergy bedding

Home

P.O. Box 2083
Mt Waverley 3149
Victoria Australia
Tel +61 (0)3 9509 5109
Fax +61 (0)3 9807 5965
Email Us

TheAllerGuard®Bedding product range was developed and patented worldwide in 1980. The dust mite and allergen protective bedding range has been available in Europe for more than 25 years and is backed by international laboratory tests to provide the highest level of protection without compromising the comfort of a good and healthy sleep.

AllerGuard® is classified in the EU as medical equipment, used and recommended in the medical industry as preventative treatment for asthma and allergy sufferers. AllerGuard® is approved and certified by the Australian Therapeutic Goods Adminstration and the Danish Medicines Agency (please also refer to notes below).

The Sensitive Choice program helps to identify companies that are committed to reduce asthma and allergy triggers.

The National Asthma Council Australia acknowledges that people with asthma and allergy - and their families - want good information to help improve their asthma and allergies more effectively.

Allerlux mattress, pillow and quilt encasings are included in the in the Sensitive Choice program and the butterfly symbol indicates a choice that will help promote better asthma and allergy care.

logcopy.gif.gif

The Asthma & Allergy Association of Denmark is an independent private body similar to the National Asthma Foundation of Australia. The use of their logo and certification is restricted to companies and products duly tested and approved to carry their endorsement.

The AllerGuard® bedding range was developed in cooperation with the Asthma & Allergy Association of Denmark to offer allergy sufferers an alternative to the traditional uncomfortable non-permeable protector systems.

For more technical information about of how the AllerGuard® micro fibre is constructed and why it works, please click here

The Therapeutic Goods Administration (TGA) is a unit of the Australian Government Department of Health and Ageing.

The objective of the Treraeputic Goods Act 1989, which came into effect on 15 February 1991, is to provide a national framework for the regulation of therapeutic goods in Australia to ensure the quality, safety and efficiency of medicines and ensure the quality, safety and perfomance of medical devices.

The Danish Medicines Agency is an agency under the Danish Ministry of Health and Prevention.

The purpose of the agency is to ensure that medicinal products used in Denmark are of satisfactory quality, are safe to use and that they have the desired effect. This is done through administering the Danish legislation on medicinal products, reimbursement, pharmacies, medical devices and euphoria.

Functionally speaking the Danish Medicines Agency compares to that of the Australia's Therapeutic Goods Administration

The Oeko-Tex® Standard 100was introduced at the beginning of the 1990s as a response to the needs of consumers and the general public for textiles which posed no risk to health. "Poison in textiles" and other negative headlines were widespread at this time and indiscriminately branded all chemicals across the board used in textile manufacturing as negative and dangerous to health.